Showing results (121-130 of 1,282) with videos related to
Sort By:
Pageof 129
Current Opinion in Lipidology|March 10, 2016
Genetic insights into statin-associated diabetes riskDaniel I Swerdlow, David PreissThe Canadian Journal of Cardiology|April 7, 2015
The new pooled cohort equations risk calculatorDavid Preiss, Søren L KristensenClinical Chemistry|August 22, 2018
Comparison between High-Sensitivity Cardiac Troponin T and Cardiac Troponin I in a Large General Population CohortPaul Welsh, David Preiss, Anoop S V Shah, et al.Cerebrovascular Diseases (Basel, Switzerland)|May 27, 2003
Low triglyceride, not low cholesterol concentration, independently predicts poor outcome following acute strokeChristopher J Weir, Naveed Sattar, Matthew R Walters, et al.Journal of Hepatology|July 3, 2024
Differing genetic variants associated with liver fat and their contrasting relationships with cardiovascular diseases and cancerAltayeb Ahmed, Madeleine Cule, Jimmy D Bell, et al.Hypertension (Dallas, Tex. : 1979)|May 14, 2003
Classic and novel risk factor parameters in women with a history of preeclampsiaNaveed Sattar, Jane Ramsay, Lynne Crawford, et al.Journal of Cardiovascular Pharmacology|December 18, 2001
Factors critical to iontophoretic assessment of vascular reactivity: implications for clinical studies of endothelial dysfunctionJane Elizabeth Ramsay, William Russell Ferrell, Ian Andrew Greer, et al.Diabetologia|August 2, 2018
Empagliflozin is associated with improvements in liver enzymes potentially consistent with reductions in liver fat: results from randomised trials including the EMPA-REG OUTCOME® trialNaveed Sattar, David Fitchett, Stefan Hantel, et al.Atherosclerosis|July 21, 2004
Pre-eclampsia and cardiovascular disease: metabolic syndrome of pregnancy?Vanessa A Rodie, Dilys J Freeman, Naveed Sattar, et al.Nature Reviews. Cardiology|May 8, 2009
Role for TNF in atherosclerosis? Lessons from autoimmune diseaseGayle E McKellar, David W McCarey, Naveed Sattar, et al.Pageof 129